|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-30
|
|
pubmed:abstractText |
The use of low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes is recommended by existing guidelines, but definitive evidence supporting its efficacy is lacking. The authors undertook a meta-analysis of published trials to determine the effect of low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1538-2990
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
341
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21191260-Aspirin,
pubmed-meshheading:21191260-Cardiovascular Diseases,
pubmed-meshheading:21191260-Diabetes Complications,
pubmed-meshheading:21191260-Dose-Response Relationship, Drug,
pubmed-meshheading:21191260-Hemorrhage,
pubmed-meshheading:21191260-Humans,
pubmed-meshheading:21191260-Myocardial Infarction,
pubmed-meshheading:21191260-Platelet Aggregation Inhibitors,
pubmed-meshheading:21191260-Primary Prevention,
pubmed-meshheading:21191260-Stroke
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
|
|
pubmed:affiliation |
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, USA.
|
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|
